Navigation Links
Nanoparticles may enhance cancer therapy
Date:2/16/2012

A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University and the University of Texas MD Anderson Cancer Center.

The work blazes a path for further research into therapy customized to the needs of individual patients. The therapy uses carbon nanoparticles to encapsulate chemotherapeutic drugs and sequester them until they are delivered to the cancer cells they are meant to kill.

A paper on the research was published this month in the American Chemical Society journal ACS Nano.

The new strategy by Rice chemist James Tour and Jeffrey Myers, a professor of head-and-neck surgery at MD Anderson, combines paclitaxel (PTX) and Cetuximab (Cet) with hydrophilic carbon clusters functionalized with polyethylene glycol, known as PEG-HCC.

Cetuximab, the targeting agent, is a humanized monoclonal antibody that binds exclusively to the epidermal growth factor receptor (EGFR), a cell-surface receptor overexpressed by 90 percent of head-and-neck squamous cell cancers. Paclitaxel, an active agent in chemotherapy, is used to treat lung, ovarian, breast and head-and-neck cancers. In combination, they have the ability to target and attack cancerous cells.

Because paclitaxel is hydrophobic it won't mix with water the substances are generally combined with Cremophor EL, a castor oil-based carrier that allows the compound marketed as Taxol to be delivered intravenously to patients.

Tour, Myers and their associates have found a simple way to mix PTX and Cetuximab with carbon clusters that adsorb the active ingredients. The new compound is water-soluble and is more effective at targeting tumors than Taxol while avoiding the toxic effects of paclitaxel and Cremophor on adjacent healthy cells, they wrote.

"It's very common to administer cortical steroids to limit the
'/>"/>

Contact: David Ruth
david@rice.edu
713-348-6327
Rice University
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Children may have highest exposure to titanium dioxide nanoparticles
2. UC Davis researchers refine nanoparticles for more accurate delivery of cancer drugs
3. In the brain, ORMOSIL nanoparticles hold promise as a potential vehicle for drug delivery
4. Nanoparticles help Mayo Clinic researcher deliver steroids to retina
5. Nanoparticles help researchers deliver steroids to retina
6. New device uses gold nanoparticles to test for lung cancer
7. Study indicates nanoparticles could help pain-relieving osteoarthritis drugs last longer
8. Consumers close encounters with nanoparticles
9. UGA researchers use gold nanoparticles to diagnose flu in minutes
10. Gold nanoparticles bring scientists closer to a treatment for cancer
11. Gold nanoparticles help earlier diagnosis of liver cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Quincy Bioscience, makers ... is pleased to announce the release of the fourth ... president and co-founder Mark Underwood. , The Brain Health ... offering useful techniques for readers to improve memory and ... unavoidable conclusion, The Brain Health Guide provides ways to ...
(Date:7/28/2014)... procedure to treat severe chronic migraine headaches led to ... time in patients treated at Massachusetts General Hospital (MGH). ... Reconstructive Surgery report that more than half of 35 ... whom had headaches associated with compression of craniofacial nerves ... The team,s paper has received advance online publication in ...
(Date:7/28/2014)... Massachusetts (PRWEB) July 28, 2014 ... Summit Provider Exchange technology solution in ... integration efforts and support collaboration with their New ... bed acute-care medical center located in New Jersey, ... seasonal visitors with a variety of inpatient and ...
(Date:7/28/2014)... runners are far more likely to die of heat ... new study. The researchers pointed out that ... actually 10 times more likely to develop severe and ... of a young and apparently healthy person due to ... gets a lot more media attention. "This research ...
(Date:7/28/2014)... The Oakwood Foundation celebrated a major gift this ... PC that will benefit each community we serve for ... The HBWS group is among the Foundation’s largest physician ... donations. Through their latest gift, they will be one ... Classic for the next 6 years; provide state-of-the-art technology ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2
... flawless video transmission will enable advances in telemedicine ... and the digital marketplace, board members say, ... enables medical, government and media customers to flawlessly,transport high-bandwidth, ... the formation of the Rivulet,Technical Advisory Board and the ...
... coalition calls for quality standards to protect Pennsylvania ... families from inadequate regulations, ... facilities to rent rooms to residents that,do not meet current ... or walkers., While new assisted living construction would be ...
... Harvard Initiative for Global Health (HIGH) has been selected ... Health grant from the National Institutes of Health,s Fogarty ... by an additional $300,000 grant from the University and ... global heath. The grant will fund the Fostering Opportunities ...
... her boyfriend, a 35-year-old woman suddenly felt her left arm ... on the left side of her face. , She was ... due to several related factors, including birth control pills, a ... , Doctors at Loyola University Medical Center describe the ...
... WALNUT CREEK, Calif., Sept. 14 Longs Drug,Stores ... that it had,received an unsolicited, non-binding expression of ... offer of $75.00 per share in cash,for all ... diligence and,negotiating a definitive agreement. Longs, Board of ...
... amplified in these malignancies, study finds , , SUNDAY, ... new genetic player in the development of colon cancer. ... gene expression in the proliferation of colorectal cancer, the ... could lead to new therapeutic approaches for colon cancer, ...
Cached Medicine News:Health News:Rivulet Communications Announces New Technical Advisory Board and Initial Board Appointments 2Health News:Rivulet Communications Announces New Technical Advisory Board and Initial Board Appointments 3Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 2Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 3Health News:Harvard University recipient of Global Health Nutrition grant 2Health News:Unusual case of a woman who suffered stroke during sex 2Health News:Unusual case of a woman who suffered stroke during sex 3Health News:Longs Drug Stores Confirms Receipt of Expression of Interest from Walgreens 2Health News:Longs Drug Stores Confirms Receipt of Expression of Interest from Walgreens 3Health News:Colon Cancer Oncogene Discovered 2Health News:Colon Cancer Oncogene Discovered 3
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator of ... in China , today announced that ... a special cash dividend of US$0.30 per ordinary share ... Company,s outstanding ordinary shares. The total expense for the ...
(Date:7/28/2014)... , July 28, 2014 ... Ventures 2,5 Millionen £ investiert hat, um ... Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche zu erfüllen. ...      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ) ... hat OmPrompt sein beschleunigtes Wachstum mit Investitionen ...
(Date:7/28/2014)... and NEW PROVIDENCE, N.J. ... engineering professionals are invited to meet with Linde,s Healthcare ... Technical Exhibition to be held at McCormick Place in ... "Hospitals demand nothing less than complete ... Mark Sanda , Linde,s Healthcare Segment manager. "Linde understands ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
... BETHESDA, Md., Dec. 19, 2011 /PRNewswire-Asia/ -- Chindex International, ... care company providing health care services in China through ... private primary care hospitals and affiliated ambulatory clinics, today ... Hospital ("TJU"), one of the latest development projects of ...
...   , First once-daily, fixed-dose preventative treatment ... heartbeat) at risk of the devastating consequences of stroke ... solution for the treatment of deep vein thrombosis (DVT) ... is now approved in the UK for the prevention ...
Cached Medicine Technology:Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 2Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 3Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 2Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 3Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 5Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 6
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: